Syringic Acid Ameliorates Bleomycin Induced Pulmonary Inflammation and Fibrosis in Rats via Maintenance of Endogenous Antioxidants and Downregulation of Pro-Inflammatory Markers

ABSTRACT

Background Chronic administration of Bleomycin (BLM), a chemotherapeutic drug, has been linked to Idiopathic Pulmonary Fibrosis (IPF). It has been observed that syringic acid, a phenolic compound, has antiapoptotic, anti-inflammatory and antioxidant properties. Objectives To assess syringic acid's therapeutic potential against lung fibrosis caused by BLM and determine potential mechanism of action. Materials and Methods Sprague-Dawley rats were inducted into IPF after receiving 7.5 IU/kg of BLM intratracheally. Syringic acid (50 mg/kg, p.o.) was administered to rats for 14 days, after which different parameters in lung and Bronchoalveolar Lavage Fluid (BALF) were measured. Results Altered BALF differential cell counts, elevated lung index, hydroxyproline, NO, MDA levels and reduction in GSH, GPx, SOD and CAT in group receiving BLM were evidence of pulmonary toxicity. Administering 50 mg/kg of syringic acid significantly reduced (p<0.001) the changes brought about by BLM. The expression of TNF-α was greatly reduced by syringic acid when it was stimulated by BLM. The BLM-treated group's histological analysis revealed significant lung damage with alveolar septal thickening, interstitial infiltration, collapsing alveolar gaps and an elevated Szapiel score. Syringic acid lessened these effects. Syringic acid group (p<0.01) markedly reduced Szapiel score, collagen deposition, lung edema and fibrotic alterations. It also inhibited infiltration of myofibroblasts and inflammatory cells, primarily macrophages and lymphocytes. This, in turn, improves control of oxidant and pro-inflammatory markers (TNF-α) to decrease collagen deposition during pulmonary fibrosis. Conclusion Finally, it is concluded that Syringic acid can protect the lung against BLM-induced pulmonary oxidative stress, inflammation and fibrosis.

KEYWORDS

• Anti-fibrotic
• Anti-inflammatory
• Antioxidant
• Bleomycin
• Pulmonary fibrosis
• Syringic acid

Showing references and in-text citations exactly as published.

• DOI10.5530/pres.20251990Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Res..

• Article · VOLUME 17, ISSUE 2Standardization and GC-MS Analysis of Phytochemicals in Coccinia indica (Wight and Arn.) FruitsShadab Alam, Mohammad Irfan Khan, Aleza Rizvi, Badruddeen, Juber Akhtar, Mohammad Ahmad, Mohammad Dabeer Ahmad · pp. 507–518Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 2Phyto-Analytical Studies and in vitro Wound Healing Activity of Synedrella nodiflora (L.) Gaertn Leaf ExtractJoshna Koodathil, Lathika Ramadass, Sindhu Jayachandran, Jaganath Sekar · pp. 519–531Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 2An Evaluation of the Oral Toxicity of Shwaskas Chintamani Rasa in Wistar Rats for 90-Days Repeated AdministrationMahalaxmi Mohan, Shubhangi Hemraj Pawar, Sanskruti Sanjay Kashmire, Shishir Purushottam Pande, Rajshree Abhay Kulkarni, Abhay Narayan Kulkarni · pp. 543–551Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 2Exploring the Therapeutic Potential of Plectranthus amboinicus: LC-MS Profiling and Molecular Docking InsightsMH Shaeena, DR Bharathi · pp. 552–561Original ArticleSame type: Article